high blood pressure tirzepatide and reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial Systolic blood pressure reduction with
Description
The approach of jump to reference multiple imputation assumes that patients instantly lose any effect from randomized treatment after discontinuation beyond what could be expected from placebo as an adjunct to diet and exercise
1064 Rasmussen, R
10.1038/nature00887 130
Notoriously, both GIPR agonists and antagonists lead to weight loss mainly when co-administrated with GLP-1 agonists or analogues (Killion et al
